Barbara Ann Karmanos Cancer Institute - Detroit Headquarters — Detroit, Michigan

Barbara Ann Karmanos Cancer Institute - Detroit Headquarters is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Institute - Detroit Headquarters has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Urothelial Carcinoma, Metastatic Hormone-sensitive Prostate Cancer, Biochemically Recurrent Prostate Cancer.

Sponsors: Bayer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Detroit

Browse all research sites in Michigan · View every site in Detroit

• Henry Ford Hospital- A-Basement Research Pharmacy
• Henry Ford Hospital /ID# 162682
• Ascension St. John's Hospital
• Henry Ford Hospital /ID# 262704
• Barbara Ann Karmanos Cancer Institute Wayne State University
• PET Center/Children's Hospital of Michigan
• CS Mott Children's Hospital
• Perinatology Research Branch Hutzel Women's Hospital
• Wayne State University School of Medicine/Detroit Receiving Hospital
• Henry Ford Hospital SC
• Hutzel Hospital
• DMC Sinai Grace Hospital

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Institute - Detroit Headquarters?

Barbara Ann Karmanos Cancer Institute - Detroit Headquarters has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Institute - Detroit Headquarters conducted?

Barbara Ann Karmanos Cancer Institute - Detroit Headquarters has 3 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma, Metastatic Hormone-sensitive Prostate Cancer, Biochemically Recurrent Prostate Cancer.

Is Barbara Ann Karmanos Cancer Institute - Detroit Headquarters accredited by Crixeo Clinical Trials?

Barbara Ann Karmanos Cancer Institute - Detroit Headquarters has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Institute - Detroit Headquarters?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.